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Chlamydia trachomatis and Chlamydophila abortus induce
the expression of secretory leukocyte protease inhibitor
in cells of the human female reproductive tract
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ABSTRACT
C. trachomatis and C. abortus are related Gram-negative intracellular bacteria that cause reproductive
failure due to infertility (C. trachomatis) or abortion (C. abortus). These organisms target epithelial cells
in the reproductive tract and/or placenta, but the innate immune mechanisms that lead to protection
or pathology and disease are poorly understood. SLPI is an innate immune molecule which protects
mucosal surfaces from infection and injury. C. trachomatis and C. abortus were found to induce SLPI
mRNA and peptide expression in HeLa (cervical epithelium) and JEG-3 cells (trophoblast) respectively.
Both cell lines constitutively expressed SLPI and, although infection enhanced this expression, killed
organisms did not. These data demonstrate that Chlamydia/Chlamydophila grow in cells that express
SLPI, suggesting that SLPI does not exert antimicrobial effects against these organisms. However, SLPI
has multiple functions, and we speculate that it may play a role in controlling tissue inflammation and
pathology.
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C. trachomatis and C. abortus, both obligate intracellular
bacterial pathogens belonging to the genus Chlamydiae,
are associatedwith reproductive failure (1).C. trachomatis
infects epithelial cells of the lower and upper reproduc-
tive tracts and has a strong association with infertility and
ectopic pregnancy. These outcomes have been linked to
inflammatory host immune responses (2). C. abortus in-
fects placental trophoblast and causes abortion in sheep
and humans. Again, this response is linked to local im-
munopathology (3). Both pathogens can induce chronic
infections. The early events following primary (acute) in-
fection are likely to be very important in determining
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progression to chronic infection. Given that acute chlamy-
dial infections are characterized by intense inflammation
and mucosal infiltration of immune cells including neu-
trophils (4), and thatChlamydiae are susceptible tonatural
antimicrobials (5, 6), it was hypothesized that innate im-
munomodulatorymoleculesmay play a role in chlamydial
infection of epithelial cells in the reproductive tract.
SLPI is a highly conserved proteinase inhibitor that is
constitutively expressed by epithelial cells, mast cells, neu-
trophils andmacrophages. SLPI is thought to protect mu-
cosal surfaces from damage during inflammation (7) act-
ing as a neutrophil elastase inhibitor (8) and controlling
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inflammation by down-regulating TNF-α production in
LPS-activatedmacrophages (9). SLPI also exhibits antimi-
crobial properties against both Gram-negative and Gram-
positive bacteria (7).
Expression of SLPI at mucosal sites such as the res-
piratory and gastrointestinal tracts can be modulated,
both positively and negatively, by pathogens. For exam-
ple, Staphylococcus aureus (10) andHelicobacter pylori (11)
can inhibit SLPI expression whereas HIV-1 (12) and M.
tuberculosis (13) can augment SLPI expression. SLPI is
expressed throughout the female reproductive tract (14)
and in human trophoblasts (15). It is an antibacterial con-
stituent of vaginal fluid (16) and cervical mucus (17). Fur-
thermore, the bactericidal activity of uterine cell washes
in culture can, at least partially, be inhibited by antibodies
that neutralize SLPI (18). Thus, it is of interest to in-
vestigate modulation of SLPI expression by pathogens of
the reproductive tract with a view to understanding the
complex host-pathogen interactions that can lead to pro-
tection or immunopathology. To address our hypothesis,
SLPI expression inHeLa229 (derived fromhumancervical
epithelium) and JEG-3 cells (derived from human placen-
tal chorionic epithelium) infected withC. trachomatis and
C. abortus respectively, was investigated.
HeLa cellswere grown to sub-confluence in IMDM, (In-
vitrogen, Paisley, UK) supplemented with 2% FBS (PAA
laboratories, Teddington, UK) in 24 well plates (Corning
Costar, High Wycombe, UK). Cells (2× 105 cells in 1ml)
were infected with C. trachomatis (Serovar E) at an esti-
matedMOI of 0.1. TheMOIwas derived by evaluating the
number of inclusion-forming units of the parent stock of
C. trachomatis EB titrated on HEp-2 cells. Infected cells
were fixed 48 hr after infection and inclusions stained us-
ing the 13/4 anti-chlamydial LPS monoclonal antibody
followed by a rabbit anti-mouse FITC conjugated anti-
body. Uninfected cells served as controls. The cells were
cultured for 4, 8, 24 or 48 hr, after which time the su-
pernates were harvested and stored at−20◦C until further
analysis for the presence of SLPI peptide by ELISA (Hycult
Biotech, Uden, the Netherlands). At harvest, the cells were
washed with cold PBS and RNA isolated using the Qiagen
RN easymini kit (Qiagen, Crawley, UK) for analysis of the
presence of mRNA encoding SLPI by quantitative real-
time RT-PCR. All reagents and equipment used for cDNA
synthesis and real-time RT-PCR analysis were from Ap-
plied Biosystems (Applied Biosystems, Warrington, UK)
unless otherwise stated. Oneμg of total RNA was reverse
transcribed using the Taqman Reverse transcription kit.
For the real-time PCR, 50 ng of cDNAwas amplified using
the forward primer 5′-TGACACTTGTGGCATCAAATG-
3′, the reverse primer 5′-CCCAGGCTTCCTCCTTGTT-3′
and the probe 5′-GGATCCTGTTGACACCCCAAACC-3′
using the TaqmanMasterMix, on an ABI 7000 Prism real-
time thermo cycler. 18S rRNA was amplified in a duplex
reaction using a validated primer: probe set as internal
control and to allow quantitation relative to baseline un-
infected control cells. Experiments were repeated at least
three times. Due to evidence of increasing variability with
increasing means, results were log10 transformed prior to
statistical analysis by two-way ANOVA which was used to
generate 95% confidence intervals.
Relative to uninfected controls, SLPI mRNA expression
was down regulated 4 hr after C. trachomatis infection
(P < 0.05; Fig. 1a). However, 24 and 48 hr after infection
there was a greater than 2.5 fold increase relative to un-
infected cells (Fig. 1a). The increase in mRNA expression
following infection was reflected in an increase in SLPI
peptide in the culture supernates after 48 hr (P < 0.05;
Fig. 1b). Measurement of SLPI peptide in the culture
supernates revealed constitutive expression in uninfected
cells. Despite the constitutive and induced expression, C.
trachomatis grows well in HeLa cells suggesting that SLPI
does not exert strong anti-chlamydial effects (19).
Since HeLa is a cell line widely-used to study C.
trachomatis biology, the question of whether the phe-
nomenon of SLPI induction is unique to that particu-
lar host-pathogen interaction is of interest. The closely-
related organism C. abortus was therefore studied in a dif-
ferent natural target cell (trophoblast). Experiments were
conducted using the same protocols as described for C.
trachomatis infection of HeLa cells with minor modifi-
cations as outlined below. Briefly, JEG-3 chorionic tro-
phoblast cells were grown to sub-confluence in 24 well
plates and infected with C. abortus at an estimated MOI
of 0.1, 1 or 10. The C. abortus stock (S26/3) was grown
in HEp2 cells and titrated as described above for C. tra-
chomatis with the exception that cells were fixed 72 hr
after infection. A lysate of uninfected HEp2 cells and UV-
killed C. abortus EB were used as further controls. The
uninfected cell lysate was used at dilutions that matched
those of the infected cells. EB were exposed to UV at
254 nm, 20mJ and inactivation was confirmed by the fail-
ure of C. abortus to grow in HEp-2 cells as determined
using the same staining protocol as that used for the titra-
tion. Supernates and cell lysates were harvested 24, 48
and 72 hr after infection and analyzed for SLPI protein
and mRNA as described above. The results are shown in
Figure 2.
Adose-dependent and time-dependent increase in SLPI
mRNAexpressionwasobservedatMOIof 1 and10at 48 hr
(2 and 7-fold respectively; P < 0.05 compared to unin-
fected cells) and 72 hr (4 and 8-fold respectively; P < 0.05
compared to uninfected cells, Fig. 2a). As for HeLa cells,
JEG-3 trophoblasts were found to constitutively release
SLPI peptide into the culture supernates (Fig. 2b). Again, a
significant increase was observed following infection with
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Fig. 1. SLPI expression in HeLa cells infected with C. trachomatis serovar
E (MOI 0.1). (a) SLPI mRNA expression. Each value represents the fold
change compared to the uninfected/untreated control cells at that time
point. 4 hr (lined bar), 8 hr (white bar), 24 hr (black bar), 48 hr (grey bar).
(b) SLPI protein secretion into the culture supernatant. 4 hour (lined bar),
8 hour (white bar), 24 hour (black bar), 48 hour (grey bar). Error bars rep-
resent the standard error of the means of four independent experiments.
∗P<0.05 increase relative to medium alone values at the specific time
point.
Fig. 2. SLPI expression in JEG-3 cells, infected with C. abortus at MOI
0.1, 1, 10, UV treated organisms or exposed to a HEp2 cell lysate pre-
pared using the samemethod used for the propagation of C. abortus. (a)
SLPI mRNA expression. Each value represents the fold change compared
to the control uninfected sample (medium alone) at that time point.
(b) SLPI protein secretion into the culture supernatant. 24 hr (lined bar),
48 hr (white bar), 72 hr (black bar). Experiments were carried out on at
least three separate occasions. Error bars represent the standard error
of the means. ∗P<0.05 different from medium control values at the
specific time point.
C. abortus at MOI of 1 (P < 0.05) and MOI of 10 at 72 hr
(P < 0.05) compared to uninfected controls (Fig. 2b).
However, there was no increase in SLPI mRNA expres-
sion or peptide when JEG-3 cells were exposed to UV-C-
irradiated (killed) C. abortus or treated with cell lysates
(Fig. 2a, b). The failure of killed organisms to induce SLPI
expression by trophoblast indicates that chlamydial inva-
sion and/or multiplication is an essential element in this
process. It also suggests that the sensory mechanism that
detects the organism, and subsequently promotes SLPI ex-
pression, is likely to be an intracellular receptor as opposed
to a cell-surface exposed pattern recognition receptor.
These data demonstrate that C. trachomatis and C.
abortus infection stimulate SLPI expression by cells in
the female reproductive tract. The requirement for inva-
sion and/or multiplication is interesting since both live
and heat-killed M. tuberculosis stimulate the expression
of SLPI mRNA in macrophages (13). The production
of antimicrobial molecules following chlamydial infec-
tion is not without precedent. Defensins have been found
in patients with C. trachomatis-induced urethritis (20).
However, given that both C. trachomatis and C. abortus
grow very well in cells that constitutively express SLPI,
and moreover induce further SLPI expression, we deduce
that SLPI does not exert potent antimicrobial effects on
these organisms. This raises the question as to the func-
tion of SLPI during chlamydial infection. We speculate
that its role is to control inflammation in a manner that
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supports chlamydial survival in vivo, possibly via mecha-
nisms that interferewith neutrophil clearance of infection.
This remains to be addressed.
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